Table 2.
EoEHSS stage scoresa
| Distal | Proximal | |||||
|---|---|---|---|---|---|---|
| Untreated | Treated | P | Untreated | Treated | P | |
| EI | 2.5 (1–3) | 1 (0–2) | 0.0049 | 2 (1–3) | 0 (0–2) | <0.0001 |
| BZH | 2.5 (2–3) | 1 (0–3) | 0.0070 | 3 (1–3) | 0 (0–2) | <0.0001 |
| DIS | 3 (3–3) | 1.5 (0–3) | 0.0002 | 2.5 (2–3) | 1 (0–3) | 0.0009 |
| LPF | 3 (2.5–3) | 3 (0–3) | 0.12 | 3 (0.75–3) | 2.5 (0–3) | 0.48 |
| EA | 0 (0–1) | 0 (0–0) | 0.18 | 0 (0–1) | 0 (0–0) | 0.042 |
| SL | 0 (0–1) | 0 (0–0) | 0.011 | 0 (0–1) | 0 (0–0) | 0.28 |
| SEA | 0 (0–0.75) | 0 (0–0.75) | 0.98 | 0 (0–0.25) | 0 (0–0) | 0.40 |
| DEC | 0 (0–0) | 0 (0–0) | 0.19 | 0 (0–0) | 0 (0–0) | 0.94 |
| Non-PEC feature mean | 0.5 (0.31–0.54) | 0.21 (0.04–0.43) | 0.0024 | 0.46 (0.24–0.52) | 0.13 (0–0.38) | 0.0003 |
aMedian (IQR). Groups were compared using Wilcoxon rank sum analyses.